Showing 4941-4950 of 20470 results for "".
- Plasmid Backbones Drive Global E. Coli Resistome Structurehttps://reachmd.com/news/plasmid-backbones-drive-global-e-coli-resistome-structure/2486058/Investigators report a plasmidome-resolved resistome analysis of 9700 Escherichia coli genomes, examining where resistance genes localize on plasmids versus chromosomes and how recurring plasmid
- Acute THC Linked to False Memories and Prospective Memory Lapseshttps://reachmd.com/news/news-summary-acute-thc-linked-to-false-memories-and-prospective-memory-lapses/2486031/Recent controlled experimental findings show that acute THC intoxication in regular cannabis users was linked to false recall and difficulties on everyday memory tasks in this
- ProstACT Part 1: TLX591‑Tx Safety and Dosimetry Readouthttps://reachmd.com/news/prostact-part-1-tlx591tx-safety-and-dosimetry-readout/2486034/Telix reports that Part 1 of the ProstACT Global Phase 3 study—the safety and dosimetry lead-in for TLX591‑Tx—achieved its primary obj
- Long-Term Safety with Bimekizumab in axSpA and PsAhttps://reachmd.com/news/bimekizumab-long-term-safety-in-axspa-and-psa-integrated-analysis/2486027/An integrated, pooled long-term safety analysis of bimekizumab 160 mg every 4 weeks is reported in adults with axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA), using a July 2023 d
- NDV‑01 Phase 2: 12‑Month CRs and Planned RESCUE Phase 3 Programhttps://reachmd.com/news/ndv01-phase-2-12month-crs-and-planned-rescue-phase-3-program/2486013/Relmada Therapeutics reported 12-month Phase 2 interim efficacy and tolerability findings for its sustained-release intravesical gemcitabine/docetaxel formulation NDV-01 in high-risk non-muscle invasive bladder cancer (NMIBC), alongside plans for a two-pathway Phase 3 RESCUE registrational
- Genetic Signals Predicting Donor Microbe Persistence After FMThttps://reachmd.com/news/genetic-signals-predicting-donor-microbe-persistence-after-fmt/2486005/Donor-microbe persistence after fecal microbiota transplantation (FMT) is described as uneven, and investigators examined biosynthetic gene clusters—groups of bacterial
- Median HbA1c by Age and Sex: Temporal Cohort Findings (2012–2024)https://reachmd.com/news/median-hba1c-by-age-and-sex-temporal-cohort-findings-20122024/2486015/Findings from three cross-sectional cohorts (2012, 2017, 2024) in Catanzaro, Southern Italy, were reported as showing broadly stable population-level median HbA1c over a 12-year span, alongside age
- Habitual Activity and Executive Function in Adolescents: Longitudinal Wearable Studyhttps://reachmd.com/news/habitual-activity-and-executive-function-in-adolescents-longitudinal-wearable-study/2485987/Across one academic year in secondary-school students, investigators reported that higher physical activity (steps/day) was associated with better perfor
- Global Study Finds Post-COVID Surge in Cosmetic Procedures, Led by Nonsurgical Fat Reductionhttps://reachmd.com/news/global-study-finds-post-covid-surge-in-cosmetic-procedures-led-by-nonsurgical-fat-reduction/2485998/A global analysis of aesthetic procedure trends suggests the COVID-19 pandemic produced both immediate and sustained shifts in cosmetic procedure demand, with notable regional differences in surgical and nonsurgical treatments.
- Evaluating a Team-Based Opioid Stewardship Programhttps://reachmd.com/news/urmc-report-low-cost-team-based-opioid-stewardship-reduced-discharge-prescribing/2485986/University of Rochester Medical Center (URMC) researchers describe a single-institution, multicomponent perioperative effort focused on discharge prescribing as a